Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Conditions:   Metastatic Breast Cancer;   Locally Advanced Breast Cancer Intervention:   Drug: Palbociclib Sponsor:   Consorzio Oncotech Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials